Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration
Authors:
- Xinping LuoXLXinping Luo
- Duan MaDMDuan Ma
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 128 (2) , 179-185
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three‐dimensional fibrin matrixJournal of Cellular Physiology, 2010
- Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Circulating oxidized LDL: a biomarker and a pathogenic factorCurrent Opinion in Lipidology, 2009
- Tissue Factor Pathway Inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaquesAtherosclerosis, 2009
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseasesNature Reviews Drug Discovery, 2007
- Tissue Factor Pathway Inhibitor-2 Is Upregulated by Vascular Endothelial Growth Factor and Suppresses Growth Factor-Induced Proliferation of Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: Results of quantitative tissue analysis using real-time RT-PCR methodAtherosclerosis, 2005
- Molecular Determinants of Vascular Smooth Muscle Cell DiversityCirculation Research, 2005
- Role for Matrix Metalloproteinase-2 in Oxidized Low-Density Lipoprotein–Induced Activation of the Sphingomyelin/Ceramide Pathway and Smooth Muscle Cell ProliferationCirculation, 2004
- Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway InhibitorBiochemistry, 1996